119 related articles for article (PubMed ID: 29156497)
21. A woman with warts, leg swelling, and deafness.
Muszynski MA; Zerbe CS; Holland SM; Kong HH
J Am Acad Dermatol; 2014 Sep; 71(3):577-80. PubMed ID: 25128101
[TBL] [Abstract][Full Text] [Related]
22. GATA2 functions at multiple steps in hemangioblast development and differentiation.
Lugus JJ; Chung YS; Mills JC; Kim SI; Grass J; Kyba M; Doherty JM; Bresnick EH; Choi K
Development; 2007 Jan; 134(2):393-405. PubMed ID: 17166922
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease.
Maeurer M; Magalhaes I; Andersson J; Ljungman P; Sandholm E; Uhlin M; Mattsson J; Ringdén O
Transplantation; 2014 Dec; 98(12):e95-6. PubMed ID: 25955344
[No Abstract] [Full Text] [Related]
24. GATA2-dependent and region-specific regulation of Gata2 transcription in the mouse midbrain.
Nozawa D; Suzuki N; Kobayashi-Osaki M; Pan X; Engel JD; Yamamoto M
Genes Cells; 2009 May; 14(5):569-82. PubMed ID: 19371385
[TBL] [Abstract][Full Text] [Related]
25. The GATA2 transcription factor negatively regulates the proliferation of neuronal progenitors.
El Wakil A; Francius C; Wolff A; Pleau-Varet J; Nardelli J
Development; 2006 Jun; 133(11):2155-65. PubMed ID: 16672344
[TBL] [Abstract][Full Text] [Related]
26. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
[TBL] [Abstract][Full Text] [Related]
27. Pneumocystis jiroveci pneumonia and GATA2 deficiency: Expanding the spectrum of the disease.
González-Lara MF; Wisniowski-Yáñez A; Pérez-Patrigeon S; Hsu AP; Holland SM; Cuellar-Rodríguez JM
J Infect; 2017 Apr; 74(4):425-427. PubMed ID: 28126493
[No Abstract] [Full Text] [Related]
28. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
29. Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma. Report of two cases.
Michalik EE; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1983 Oct; 119(10):831-5. PubMed ID: 6614952
[TBL] [Abstract][Full Text] [Related]
30. Skin manifestations among GATA2-deficient patients.
Polat A; Dinulescu M; Fraitag S; Nimubona S; Toutain F; Jouneau S; Poullot E; Droitcourt C; Dupuy A
Br J Dermatol; 2018 Mar; 178(3):781-785. PubMed ID: 28440875
[TBL] [Abstract][Full Text] [Related]
31. In vivo single cell analysis reveals Gata2 dynamics in cells transitioning to hematopoietic fate.
Eich C; Arlt J; Vink CS; Solaimani Kartalaei P; Kaimakis P; Mariani SA; van der Linden R; van Cappellen WA; Dzierzak E
J Exp Med; 2018 Jan; 215(1):233-248. PubMed ID: 29217535
[TBL] [Abstract][Full Text] [Related]
32. Loss of the Hematopoietic Stem Cell Factor GATA2 in the Osteogenic Lineage Impairs Trabecularization and Mechanical Strength of Bone.
Tolkachov A; Fischer C; Ambrosi TH; Bothe M; Han CT; Muenzner M; Mathia S; Salminen M; Seifert G; Thiele M; Duda GN; Meijsing SH; Sauer S; Schulz TJ; Schupp M
Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581184
[TBL] [Abstract][Full Text] [Related]
33. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
34. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
35. GATA2 is required for lymphatic vessel valve development and maintenance.
Kazenwadel J; Betterman KL; Chong CE; Stokes PH; Lee YK; Secker GA; Agalarov Y; Demir CS; Lawrence DM; Sutton DL; Tabruyn SP; Miura N; Salminen M; Petrova TV; Matthews JM; Hahn CN; Scott HS; Harvey NL
J Clin Invest; 2015 Aug; 125(8):2979-94. PubMed ID: 26214525
[TBL] [Abstract][Full Text] [Related]
36. The STAT5-GATA2 pathway is critical in basophil and mast cell differentiation and maintenance.
Li Y; Qi X; Liu B; Huang H
J Immunol; 2015 May; 194(9):4328-38. PubMed ID: 25801432
[TBL] [Abstract][Full Text] [Related]
37. GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway.
Wang Z; Yuan H; Sun C; Xu L; Chen Y; Zhu Q; Zhao H; Huang Q; Dong J; Lan Q
Med Oncol; 2015 Apr; 32(4):87. PubMed ID: 25707769
[TBL] [Abstract][Full Text] [Related]
38. Effects of in vivo deletion of GATA2 in bone marrow stromal cells.
Hasegawa S; Fujiwara T; Okitsu Y; Kato H; Sato Y; Fukuhara N; Onishi Y; Shimizu R; Yamamoto M; Harigae H
Exp Hematol; 2017 Dec; 56():31-45.e2. PubMed ID: 28866324
[TBL] [Abstract][Full Text] [Related]
39. Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes.
Chong CE; Venugopal P; Stokes PH; Lee YK; Brautigan PJ; Yeung DTO; Babic M; Engler GA; Lane SW; Klingler-Hoffmann M; Matthews JM; D'Andrea RJ; Brown AL; Hahn CN; Scott HS
Leukemia; 2018 Jan; 32(1):194-202. PubMed ID: 28642594
[TBL] [Abstract][Full Text] [Related]
40. Treatment of lentigo maligna and lentigo maligna melanoma.
Pitman GH; Kopf AW; Bart RS; Casson PR
J Dermatol Surg Oncol; 1979 Sep; 5(9):727-37. PubMed ID: 489814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
